Cargando…

New developments in the pharmacotherapy of neuropathic chronic pelvic pain

Advancements in further understanding the pathophysiology of chronic pelvic pain syndromes continue to direct therapy. The mechanisms of chronic pelvic pain are often multifactorial and therefore require a multidisciplinary approach. The final treatment plan is often an accumulation of organ-specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Carey, Erin T, As-Sanie, Sawsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242194/
https://www.ncbi.nlm.nih.gov/pubmed/28116131
http://dx.doi.org/10.4155/fsoa-2016-0048
_version_ 1782496307398574080
author Carey, Erin T
As-Sanie, Sawsan
author_facet Carey, Erin T
As-Sanie, Sawsan
author_sort Carey, Erin T
collection PubMed
description Advancements in further understanding the pathophysiology of chronic pelvic pain syndromes continue to direct therapy. The mechanisms of chronic pelvic pain are often multifactorial and therefore require a multidisciplinary approach. The final treatment plan is often an accumulation of organ-specific treatment and chronic pain medications directed to the CNS and PNS. This article is a review of commonly used medications for chronic pelvic neuropathic pain disorders as well as an introduction to recent innovative developments in pain medicine.
format Online
Article
Text
id pubmed-5242194
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Future Science Ltd
record_format MEDLINE/PubMed
spelling pubmed-52421942017-01-23 New developments in the pharmacotherapy of neuropathic chronic pelvic pain Carey, Erin T As-Sanie, Sawsan Future Sci OA Review Advancements in further understanding the pathophysiology of chronic pelvic pain syndromes continue to direct therapy. The mechanisms of chronic pelvic pain are often multifactorial and therefore require a multidisciplinary approach. The final treatment plan is often an accumulation of organ-specific treatment and chronic pain medications directed to the CNS and PNS. This article is a review of commonly used medications for chronic pelvic neuropathic pain disorders as well as an introduction to recent innovative developments in pain medicine. Future Science Ltd 2016-10-05 /pmc/articles/PMC5242194/ /pubmed/28116131 http://dx.doi.org/10.4155/fsoa-2016-0048 Text en © Erin T Carey, MD MSCR This work is licensed under a Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Review
Carey, Erin T
As-Sanie, Sawsan
New developments in the pharmacotherapy of neuropathic chronic pelvic pain
title New developments in the pharmacotherapy of neuropathic chronic pelvic pain
title_full New developments in the pharmacotherapy of neuropathic chronic pelvic pain
title_fullStr New developments in the pharmacotherapy of neuropathic chronic pelvic pain
title_full_unstemmed New developments in the pharmacotherapy of neuropathic chronic pelvic pain
title_short New developments in the pharmacotherapy of neuropathic chronic pelvic pain
title_sort new developments in the pharmacotherapy of neuropathic chronic pelvic pain
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242194/
https://www.ncbi.nlm.nih.gov/pubmed/28116131
http://dx.doi.org/10.4155/fsoa-2016-0048
work_keys_str_mv AT careyerint newdevelopmentsinthepharmacotherapyofneuropathicchronicpelvicpain
AT assaniesawsan newdevelopmentsinthepharmacotherapyofneuropathicchronicpelvicpain